Neoadjuvant Darovasertib in Primary Uveal Melanoma
Clinical trial NCT07015190 · RECRUITING
Trial details
- NCT number
- NCT07015190
- Sponsor
- IDEAYA Biosciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-25
- Primary completion
- 2030-10-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.